Repository logo
 

Severe Paradoxical Disease Activation Following Alemtuzumab Treatment for Multiple Sclerosis.

Published version
Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/304814

Repository DOI

https://doi.org/10.17863/CAM.51896
Thumbnail Image

Files

Published version (303.45 KB)
 Accepted version (24.69 KB) (Embargoed until: 2100-01-01)

Type

Article

Change log

Authors

Abstract

A 39-year old right-handed agricultural service engineer developed rapidly evolving severe relapsing-remitting Multiple Sclerosis (MS). MR imaging showed multiple T2 hyperintensities throughout his neuro-axis (Figure 1A). Several lesions showed restricted diffusion, and two enhanced. He received steroids for each relapse, making a full recovery (EDSS 0).

Description

Keywords

Adult, Alemtuzumab, Electroencephalography, Humans, Immunologic Factors, Magnetic Resonance Imaging, Multiple Sclerosis, Relapsing-Remitting

Journal Title

Neurology: Neuroimmunology and NeuroInflammation

Conference Name

Journal ISSN

2332-7812
2332-7812

Volume Title

7

Publisher

Lippincott Williams and Wilkins

Publisher DOI

https://doi.org/10.1212/NXI.0000000000000799

Rights and licensing

Attribution 4.0 International (CC BY)
Except where otherwised noted, this item's license is described as Attribution 4.0 International (CC BY)
Sponsorship
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Wellcome Trust

Collections

University of Cambridge Research Outputs (Articles and Conferences)